ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2020; 4(3): 103-106


Diffuse large B-cell lymphoma of the leg involving the gastrocnemius muscles: a case report

Iftikhar Ahmad, Mehjabeen Marri, Sadaf Noor.



Abstract
Download PDF Cited by 0 ArticlesPost

Background: Extra-nodal diffuse large B-cell lymphoma (DLBCL) is an exceedingly uncommon disease.
Case Presentation: Herein, we report a case of a 60-year-old male patient who presented with DLBCL of the left leg, and involving the gastrocnemius muscle. The patient received CHOP regimen-based neoadjuvant chemotherapy (i.e., six courses of cyclophosphamide, doxorubicin, vincristine, and prednisone), which reduced the tumor size to the point where complete resection became possible. Afterward, the tumor was completely resected. The tumor bed subsequently received conventional radiotherapy (i.e., 36 Gy/18 fractions). The patient is being followed up regularly and has remained disease-free for over 1.5 years.
Conclusion: This case demonstrates that DLBCL is an aggressive malignancy but can be effectively managed with multi-modality treatment strategy.

Key words: Diffuse large B-cell lymphoma, CHOP regimen, R-CHOP regimen, non-Hodgkins lymphoma, radiotherapy







Bibliomed Article Statistics

27
29
24
23
32
31
22
26
23
22
18
15
R
E
A
D
S

10

8

11

7

9

9

13

9

6

10

10

6
D
O
W
N
L
O
A
D
S
020304050607080910111201
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.